Protection – Talk Bio

Sanofi’s Beyfortus Achieves Blockbuster Status, Poised for Further Growth in US Market

3 months ago talkbio0Tagged Antibodies, Beyfortus, blockbuster sales, Growth, Infant, Market, Protection, Respiratory syncytial virus, sanofi, U.S.

Beyfortus, RSV antibody, Sanofi, blockbuster sales, US market growth, infant protection, respiratory syncytial virus

Leyden Labs Secures $70 Million Funding to Develop Broad Protection Against Respiratory Viruses

3 months ago talkbio0Tagged biotech, Laboratory test finding, Leyden, Mucosal Protection Platform, Nasal, Nasal defenses, PanFlu, Protection, Respiratory viruses

Leyden Labs, Respiratory viruses, Influenza, Nasal defenses, Broad protection, PanFlu, Mucosal Protection Platform, Biotech funding

AstraZeneca’s COVID-19 Antibody Treatment Shows Promising Results in Immunocompromised Individuals

11 months ago talkbio0Tagged Antibodies, AstraZeneca, Clinical Trials, COVID19 (disease), Enhance (action), Immune response, Immunocompromised Host, individuals, Monoclonal Antibodies, Neutralization (Chemistry), Protection, Virus

AstraZeneca, COVID-19, antibody treatment, immunocompromised individuals, enhanced protection, clinical trials, monoclonal antibodies, virus neutralization, immune response.